381 related articles for article (PubMed ID: 1750431)
21. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.
Akin C; Schwartz LB; Kitoh T; Obayashi H; Worobec AS; Scott LM; Metcalfe DD
Blood; 2000 Aug; 96(4):1267-73. PubMed ID: 10942367
[TBL] [Abstract][Full Text] [Related]
22. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
23. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
[TBL] [Abstract][Full Text] [Related]
24. Systemic mast cell disease presenting with peripheral blood eosinophilia.
Miranda RN; Esparza AR; Sambandam S; Medeiros LJ
Hum Pathol; 1994 Jul; 25(7):727-30. PubMed ID: 8026833
[TBL] [Abstract][Full Text] [Related]
25. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P
Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677
[TBL] [Abstract][Full Text] [Related]
26. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
27. [Systemic mast cell disease associated with cutaneous xanthomas and markedly elevated serum IgE].
Hino N; Yamabe T; Ono T; Sasaki N; Nanba K
Rinsho Ketsueki; 1990 Sep; 31(9):1478-82. PubMed ID: 2246820
[TBL] [Abstract][Full Text] [Related]
28. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
29. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
30. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
Oranje AP; Mulder PG; Heide R; Tank B; Riezebos P; van Toorenenbergen AW
Clin Exp Dermatol; 2002 Sep; 27(6):502-6. PubMed ID: 12372095
[TBL] [Abstract][Full Text] [Related]
31. Solid and hematologic malignancies in 60 patients with systemic mast cell disease.
Travis WD; Li CY; Bergstralh EJ
Arch Pathol Lab Med; 1989 Apr; 113(4):365-8. PubMed ID: 2650653
[TBL] [Abstract][Full Text] [Related]
32. Mast cell leukemia: report of a case and review of the literature.
Travis WD; Li CY; Hoagland HC; Travis LB; Banks PM
Mayo Clin Proc; 1986 Dec; 61(12):957-66. PubMed ID: 3095598
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations.
Tebbe B; Stavropoulos PG; Krasagakis K; Orfanos CE
Dermatology; 1998; 197(2):101-8. PubMed ID: 9732155
[TBL] [Abstract][Full Text] [Related]
34. Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults.
Topar G; Staudacher C; Geisen F; Gabl C; Fend F; Herold M; Greil R; Fritsch P; Sepp N
Am J Clin Pathol; 1998 Mar; 109(3):279-85. PubMed ID: 9495199
[TBL] [Abstract][Full Text] [Related]
35. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
36. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.
Kettelhut BV; Parker RI; Travis WD; Metcalfe DD
Am J Clin Pathol; 1989 May; 91(5):558-62. PubMed ID: 2470248
[TBL] [Abstract][Full Text] [Related]
37. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
[TBL] [Abstract][Full Text] [Related]
38. Pathology of the lymph node and spleen in systemic mast cell disease.
Travis WD; Li CY
Mod Pathol; 1988 Jan; 1(1):4-14. PubMed ID: 3237690
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
40. Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
Akin C; Scott LM; Metcalfe DD
Leuk Res; 2001 Jul; 25(7):635-8. PubMed ID: 11377688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
